HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yibin Feng Selected Research

huanglian

12/2015Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives.
12/2013Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.
1/2011Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract.
12/2010Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism.
10/2009Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yibin Feng Research Topics

Disease

56Neoplasms (Cancer)
11/2023 - 07/2009
45Hepatocellular Carcinoma (Hepatoma)
04/2024 - 12/2010
15Inflammation (Inflammations)
07/2023 - 09/2015
14Liver Diseases (Liver Disease)
02/2024 - 07/2009
10Neoplasm Metastasis (Metastasis)
06/2020 - 07/2009
9Carcinogenesis
02/2024 - 09/2015
8Fibrosis (Cirrhosis)
02/2024 - 01/2016
8Non-alcoholic Fatty Liver Disease
02/2024 - 01/2016
8Diabetic Retinopathy (Retinopathy, Diabetic)
01/2024 - 07/2015
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 08/2009
7Liver Neoplasms (Liver Cancer)
02/2024 - 12/2010
4Fatty Liver
02/2024 - 09/2017
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
02/2024 - 11/2015
4Insulin Resistance
01/2024 - 01/2018
4COVID-19
05/2023 - 01/2021
4Carcinoma (Carcinomatosis)
10/2020 - 12/2010
3Hepatitis
02/2024 - 09/2017
3Diabetes Mellitus
11/2021 - 01/2021
3Obesity
04/2021 - 01/2019
3Breast Neoplasms (Breast Cancer)
01/2021 - 01/2020
3Diarrhea
01/2021 - 01/2020
3Vomiting
01/2021 - 07/2009
3Wounds and Injuries (Trauma)
01/2020 - 07/2009
2Infections
02/2024 - 01/2019
2Adenocarcinoma
04/2023 - 01/2021
2Nausea
01/2021 - 01/2020
2Metabolic Diseases (Metabolic Disease)
01/2021 - 01/2017
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 01/2020
2Body Weight (Weight, Body)
06/2020 - 07/2009
2Hyperglycemia
07/2015 - 12/2008
2Nasopharyngeal Carcinoma
12/2013 - 07/2009
1Alzheimer Disease (Alzheimer's Disease)
05/2024
1Cholestasis
02/2024
1Digestive System Diseases
02/2024

Drug/Important Bio-Agent (IBA)

21BerberineIBA
02/2024 - 07/2009
13Plant ExtractsIBA
11/2023 - 01/2011
9Therapeutic UsesIBA
05/2023 - 06/2014
9LipidsIBA
01/2022 - 12/2017
8AntioxidantsIBA
01/2024 - 07/2009
7Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2008
7MicroRNAs (MicroRNA)IBA
10/2020 - 01/2011
5Amino AcidsFDA Link
02/2024 - 02/2020
5Insulin (Novolin)FDA Link
01/2024 - 06/2020
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2014
5huanglianIBA
12/2015 - 10/2009
4Sorafenib (BAY 43-9006)FDA Link
04/2024 - 01/2018
4Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
4Retinaldehyde (Retinal)IBA
01/2021 - 07/2015
3he-ying-qing-reIBA
01/2024 - 07/2015
3AlbuminsIBA
11/2023 - 01/2022
3CytokinesIBA
05/2023 - 01/2018
3Fatty Acids (Saturated Fatty Acids)IBA
04/2023 - 02/2018
3Reactive Oxygen Species (Oxygen Radicals)IBA
04/2023 - 09/2018
3Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 10/2013
3genipinIBA
01/2023 - 01/2012
3Glucose (Dextrose)FDA LinkGeneric
09/2021 - 02/2020
3huanglian-jie-du decoctionIBA
01/2020 - 04/2015
3Ethanol (Ethyl Alcohol)IBA
01/2019 - 01/2018
2QuercetinIBA
05/2024 - 05/2023
2Choline (Choline Chloride)IBA
02/2024 - 01/2021
2EnzymesIBA
01/2024 - 12/2017
2CarbohydratesIBA
01/2024 - 01/2022
2Sirtuin 1IBA
01/2024 - 07/2021
2LuteolinIBA
01/2024 - 05/2023
2Indicators and Reagents (Reagents)IBA
11/2023 - 01/2022
2Emodin (Archin)IBA
03/2023 - 01/2019
2fangchinoline (limacine)IBA
01/2023 - 09/2011
2CreatinineIBA
01/2023 - 01/2022
2Polysaccharides (Glycans)IBA
10/2022 - 08/2020
2SeleniumIBA
05/2022 - 01/2017
2Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 01/2021
2NucleotidesIBA
01/2022 - 02/2020
2Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 01/2021
2Advanced Glycation End ProductsIBA
11/2021 - 12/2011
2SaponinsIBA
04/2021 - 01/2020
2gegenqinlianIBA
01/2021 - 01/2015
2Long Noncoding RNAIBA
10/2020 - 01/2019
2Alanine Transaminase (SGPT)IBA
07/2020 - 01/2018
2CurcuminIBA
01/2020 - 06/2016
2AcidsIBA
01/2020 - 07/2009
2tetrandrineIBA
01/2020 - 02/2017
2PolyphenolsIBA
08/2019 - 01/2018
2CateninsIBA
01/2018 - 12/2017
2PhytochemicalsIBA
01/2018 - 12/2015
2Analgesics (Analgesic Drugs)IBA
01/2017 - 01/2017
2AlkaloidsIBA
09/2014 - 12/2010
1Death-Associated Protein KinasesIBA
05/2024
1CRISPR-Cas Systems Guide RNAIBA
02/2024
1Methionine (L-Methionine)FDA Link
02/2024
1CDAA (Randox)IBA
02/2024

Therapy/Procedure

31Therapeutics
05/2023 - 07/2009
11Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2023 - 06/2014
8Drug Therapy (Chemotherapy)
01/2021 - 10/2013
3Complementary Therapies (Alternative Medicine)
11/2023 - 08/2015
3Immunotherapy
01/2023 - 01/2018
2Liver Transplantation
02/2024 - 06/2020
2Traditional Medicine (Folk Remedies)
02/2018 - 01/2016
2Ligation
01/2016 - 11/2012